TY - JOUR
T1 - Lung Cancer Screening Among Mammography Patients
T2 - Knowledge, Eligibility, Participation, and Interest
AU - Novogrodsky, Eitan
AU - Haramati, Linda B.
AU - Villasana-Gomez, Geraldine M.
AU - Goldman, Jessica
AU - Rosenfeld, Cyril
AU - Rosenblum, Jessica K.
AU - Sayre, James W.
AU - Hoyt, Anne C.
AU - Goldin, Jonathan G.
AU - Milch, Hannah S.
N1 - Publisher Copyright:
© 2023 American Board of Family Medicine. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Objective: To determine lung cancer screening eligibility, knowledge, and interest and to quantify the effect of the expanded 2021 lung cancer screening eligibility criteria among women presenting for screening mammography, a group with demonstrable interest in cancer screening. Methods: A single-page survey was distributed to patients presenting for screening mammography, from January-March 2020 and June 2020-January 2021, at 2 academic medical centers on the East and West Coasts. The population served by the East Coast institution has greater poverty, greater ethnic/racial diversity, and lower education levels. Survey questions included age, smoking history, lung cancer screening knowledge, participation, and interest. Lung cancer screening eligibility was determined for both 2013 and 2021 USPSTF guidelines. Descriptive statistics were calculated, and data were compared between groups using the Chi-square test, Mann-Whitney nonparametric test, and the 2-sample t test. Results: 5512 surveys were completed; 33% (1824) of women reported a history of smoking-30% (1656) former smokers and 3% (156) current smokers. Among women with a smoking history, 7% (127/1824) were eligible for lung cancer screening using 2013% and 11% (207/1824) using the 2021 USPSTF criteria. Interest in lung cancer screening was high (73%; 151/207) among eligible women using 2021 USPSTF criteria, but only 42% (87/207) had heard of lung cancer screening and only 28% (57/207) had received prior LDCT screening. Conclusion: Eligible screening mammography patients reported high levels of interest in lung cancer screening but low levels of knowledge and participation. Linking mammography and LDCT appointments may improve lung cancer screening participation.
AB - Objective: To determine lung cancer screening eligibility, knowledge, and interest and to quantify the effect of the expanded 2021 lung cancer screening eligibility criteria among women presenting for screening mammography, a group with demonstrable interest in cancer screening. Methods: A single-page survey was distributed to patients presenting for screening mammography, from January-March 2020 and June 2020-January 2021, at 2 academic medical centers on the East and West Coasts. The population served by the East Coast institution has greater poverty, greater ethnic/racial diversity, and lower education levels. Survey questions included age, smoking history, lung cancer screening knowledge, participation, and interest. Lung cancer screening eligibility was determined for both 2013 and 2021 USPSTF guidelines. Descriptive statistics were calculated, and data were compared between groups using the Chi-square test, Mann-Whitney nonparametric test, and the 2-sample t test. Results: 5512 surveys were completed; 33% (1824) of women reported a history of smoking-30% (1656) former smokers and 3% (156) current smokers. Among women with a smoking history, 7% (127/1824) were eligible for lung cancer screening using 2013% and 11% (207/1824) using the 2021 USPSTF criteria. Interest in lung cancer screening was high (73%; 151/207) among eligible women using 2021 USPSTF criteria, but only 42% (87/207) had heard of lung cancer screening and only 28% (57/207) had received prior LDCT screening. Conclusion: Eligible screening mammography patients reported high levels of interest in lung cancer screening but low levels of knowledge and participation. Linking mammography and LDCT appointments may improve lung cancer screening participation.
KW - Breast Cancer
KW - Cancer
KW - Early Detection of Cancer
KW - Health Promotion
KW - Lung Cancer
KW - Mammography
KW - Patient Adherence
KW - Preventive Medicine
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85167844434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85167844434&partnerID=8YFLogxK
U2 - 10.3122/jabfm.2022.220423R1
DO - 10.3122/jabfm.2022.220423R1
M3 - Article
C2 - 37321658
AN - SCOPUS:85167844434
SN - 1557-2625
VL - 36
SP - 557
EP - 564
JO - Journal of the American Board of Family Medicine
JF - Journal of the American Board of Family Medicine
IS - 4
ER -